NewGenIVF Group (NIVF) announced that it intends to execute its previously authorized share repurchase program initially announced on November 10, 2025 through The Benchmark Company, a subsidiary of StoneX Group. Management believes that NewGen’s current market valuation does not fully reflect the Company’s underlying business fundamentals, ongoing initiatives, and long-term strategic potential. The use of Benchmark represents a key step in the disciplined implementation of the Company’s capital allocation strategy and underscores management’s confidence in NewGen’s future trajectory.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NIVF:
- Upcoming Stock Splits This Week (January 26 to January 30) – Stay Invested
- NewGenIvf Group Ltd trading halted, news pending
- NewGenIvf appoints Joshua Chu as Senior Counsel for tokenization strategy
- NewGenIvf Group to Implement 1-for-3 Reverse Stock Split Effective January 26, 2026
- NewGenIvf to convert Ras AI Khaimah Joint Venture into Joint Development